Vivesto AB

OMAX

Company Profile

  • Business description

    Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.

  • Contact

    Gustav III:s Boulevard 46
    5th Floor
    SolnaSE-169 73
    SWE

    T: +46 18505440

    E: [email protected]

    https://www.vivesto.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    4

Stocks News & Analysis

stocks

How I lost all my savings through a poor investment decision

With first timers at risk of poor investment decisions and an interest in speculative stocks, I explore my biggest investing mistake.
stocks

Our view of Nvidia / OpenAI deal

Big AI dreams as firms announce a strategic partnership.
stocks

Chart of the Week: Morningstar’s forecast for CSL’s future

We see gross margin expansion on efficiencies and limited tariff impact

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,063.4033.900.38%
CAC 407,808.9018.55-0.24%
DAX 4023,594.9071.91-0.30%
Dow JONES (US)46,121.28171.50-0.37%
FTSE 1009,227.3523.08-0.25%
HKSE26,443.9674.69-0.28%
NASDAQ22,497.8675.62-0.33%
Nikkei 22545,754.93124.620.27%
NZX 50 Index13,153.7927.52-0.21%
S&P 5006,637.9718.95-0.28%
S&P/ASX 2008,773.0035.100.40%
SSE Composite Index3,853.300.34-0.01%

Market Movers